Skip to main content
Advertisement
Advertisement

GMAB

GMAB logo

Genmab A/S ADS

37.07
USD
Sponsored
+1.02
+2.83%
Oct 09, 16:00 UTC -4
Closed
exchange

After-Market

37.06

-0.01
-0.03%

GMAB Earnings Reports

Positive Surprise Ratio

GMAB beat 27 of 42 last estimates.

64%

Next Report

Date of Next Report
Nov 05, 2026
Estimate for Q3 26 (Revenue/ EPS)
$1.24B
/
$4.10
Implied change from Q2 26 (Revenue/ EPS)
+7.23%
/
-16.50%
Implied change from Q3 25 (Revenue/ EPS)
+21.19%
/
-36.53%

Genmab A/S ADS earnings per share and revenue

On Aug 06, 2026, GMAB reported earnings of 4.91 USD per share (EPS) for Q2 26, beating the estimate of 3.59 USD, resulting in a 36.61% surprise. Revenue reached 1.16 billion, compared to an expected 1.13 billion, with a 1.98% difference. The market reacted with a +1.95% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 6 analysts forecast an EPS of 4.10 USD, with revenue projected to reach 1.24 billion USD, implying an decrease of -16.50% EPS, and increase of 7.23% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Inventiva S.A. - ADR
Report Date
Sep 28, 2026 For Q2 26
Estimate
-$0.37
Actual
-$0.25
Surprise
+33.55%
logo
Palatin Technologies, Inc. Common Stock
Report Date
Sep 28, 2026 For Q4 26
Estimate
-$1.21
Actual
-$1.11
Surprise
+8.42%
FAQ
For Q2 2026, Genmab A/S ADS reported EPS of $4.91, beating estimates by 36.61%, and revenue of $1.16B, 1.98% above expectations.
The stock price moved up 1.95%, changed from $29.26 before the earnings release to $29.83 the day after.
The next earning report is scheduled for Nov 05, 2026.
Based on 6 analysts, Genmab A/S ADS is expected to report EPS of $4.10 and revenue of $1.24B for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement